377 related items for PubMed ID: 8984708
41. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC, Hallett C, Harris TA.
Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
[Abstract] [Full Text] [Related]
42. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
Wales D, Makker H, Kane J, McDowell P, O'Driscoll BR.
Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
[Abstract] [Full Text] [Related]
43. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.
Adams N, Bestall JM, Lasserson TJ, Jones PW.
Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002310. PubMed ID: 15846637
[Abstract] [Full Text] [Related]
44. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.
Adams N, Lasserson TJ, Cates CJ, Jones PW.
Cochrane Database Syst Rev; 2007 Oct 17; 2007(4):CD002310. PubMed ID: 17943772
[Abstract] [Full Text] [Related]
45. Effects of oral and inhaled corticosteroid on lymphocyte beta2-adrenoceptor function in asthmatic patients.
Tan KS, McFarlane LC, Lipworth BJ.
Br J Clin Pharmacol; 1997 Dec 17; 44(6):565-8. PubMed ID: 9431832
[Abstract] [Full Text] [Related]
46. Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma.
Ninan TK, Reid IW, Carter PE, Smail PJ, Russell G.
Thorax; 1993 Jun 17; 48(6):599-602. PubMed ID: 8346487
[Abstract] [Full Text] [Related]
47. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A.
Ann Allergy Asthma Immunol; 1997 Apr 17; 78(4):356-62. PubMed ID: 9109702
[Abstract] [Full Text] [Related]
48. Fluticasone propionate in asthma: a long term dose comparison study.
Verona E, Petrov D, Cserhati E, Hofman J, Geppe N, Medley H, Hughes S.
Arch Dis Child; 2003 Jun 17; 88(6):503-9. PubMed ID: 12765916
[Abstract] [Full Text] [Related]
49. Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults.
Wilson AM, Brewster HJ, Lipworth BJ.
J Allergy Clin Immunol; 1998 Nov 17; 102(5):751-6. PubMed ID: 9819291
[Abstract] [Full Text] [Related]
50. Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide.
Volovitz B, Kauschansky A, Nussinovitch M, Harel L, Varsano I.
J Allergy Clin Immunol; 1995 Dec 17; 96(6 Pt 1):874-8. PubMed ID: 8543743
[Abstract] [Full Text] [Related]
51. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov 17; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
52. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
J Clin Pharmacol; 2001 Dec 17; 41(12):1329-38. PubMed ID: 11762560
[Abstract] [Full Text] [Related]
53. Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test.
Pescollderungg L, Radetti G, Gottardi E, Peroni DG, Pietrobelli A, Boner AL.
Thorax; 2003 Mar 17; 58(3):227-30. PubMed ID: 12612299
[Abstract] [Full Text] [Related]
54. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
Lötvall J, Langley S, Woodcock A.
Respir Res; 2006 Aug 18; 7(1):110. PubMed ID: 16919161
[Abstract] [Full Text] [Related]
55. Budesonide treatment of moderate and severe asthma in children: a dose-response study.
Pedersen S, Hansen OR.
J Allergy Clin Immunol; 1995 Jan 18; 95(1 Pt 1):29-33. PubMed ID: 7822661
[Abstract] [Full Text] [Related]
56. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
Thorsson L, Edsbäcker S, Källén A, Löfdahl CG.
Br J Clin Pharmacol; 2001 Nov 18; 52(5):529-38. PubMed ID: 11736861
[Abstract] [Full Text] [Related]
57. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
Thorax; 1999 Mar 18; 54(3):207-12. PubMed ID: 10325895
[Abstract] [Full Text] [Related]
58. Fluticasone versus beclomethasone or budesonide for chronic asthma.
Adams N, Bestall JM, Jones PW.
Cochrane Database Syst Rev; 2002 Mar 18; (1):CD002310. PubMed ID: 11869636
[Abstract] [Full Text] [Related]
59. Effects of inhaled fluticasone propionate and oral prednisolone on lymphocyte beta 2-adrenoceptor function in asthmatic patients.
Tan KS, Grove A, Cargill RI, McFarlane LC, Lipworth BJ.
Chest; 1996 Feb 18; 109(2):343-7. PubMed ID: 8620703
[Abstract] [Full Text] [Related]
60. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
Kidney JC, Boulet LP, Hargreave FE, Deschesnes F, Swystun VA, O'Byrne PM, Choudry N, Morris MM, Jennings B, Andersson N, Andreasson A, Cockcroft DW.
J Allergy Clin Immunol; 1997 Jul 18; 100(1):65-70. PubMed ID: 9257789
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
